Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations

February 6, 2018

Responsive image

BRIDGEWATER, N.J., Feb. 6, 2018 /PRNewswire/ — Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that Andrew S. Boyer, 52, has joined Amneal as Executive Vice President, Commercial Operations and is expected to serve in the same capacity for the new…

Category: Precious Metals